These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 10995394)
1. Pharmacogenetics and the treatment of cardiovascular disease. Wilkins MR; Roses AD; Clifford CP Heart; 2000 Oct; 84(4):353-4. PubMed ID: 10995394 [No Abstract] [Full Text] [Related]
2. Pharmacogenomics and management of cardiovascular disease. Howe LA Nurse Pract; 2009 Aug; 34(8):28-35; quiz 36. PubMed ID: 19638892 [No Abstract] [Full Text] [Related]
3. Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy. Mango R; Vecchione L; Raso B; Borgiani P; Brunetti E; Mehta JL; Lauro R; Romeo F; Novelli G Expert Opin Pharmacother; 2005 Dec; 6(15):2565-76. PubMed ID: 16316297 [TBL] [Abstract][Full Text] [Related]
4. [Pharmacogenetics--new perspectives in the treatment of cardiovascular diseases]. Dzida G Kardiol Pol; 2004 Mar; 60(3):304-8. PubMed ID: 15156230 [No Abstract] [Full Text] [Related]
5. From SNPs to functional studies in cardiovascular pharmacogenomics. Cresci S Methods Mol Biol; 2008; 448():379-93. PubMed ID: 18370238 [TBL] [Abstract][Full Text] [Related]
6. Use of contemporary genetics in cardiovascular diagnosis. George AL Circulation; 2014 Nov; 130(22):1971-80. PubMed ID: 25421045 [TBL] [Abstract][Full Text] [Related]
7. Workshop outcomes report: initiatives to establish a European Network of pharmacogenetics/genomics and progress. Maitland-van der Zee AH; Aitchison K; Kirchheiner J; Eur J Pharm Sci; 2007 Jul; 31(3-4):151-5. PubMed ID: 17452095 [No Abstract] [Full Text] [Related]
8. Cardiovascular pharmacogenetics: on the way toward individually tailored drug therapy. Siffert W Kidney Int Suppl; 2003 May; (84):S168-71. PubMed ID: 12694337 [TBL] [Abstract][Full Text] [Related]
9. New collaborations make pharmacogenomics a SNP. Dawson E Mol Med Today; 1999 Jul; 5(7):280. PubMed ID: 10377514 [No Abstract] [Full Text] [Related]
10. Pharmacogenomics: the genetics of variable drug responses. Roden DM; Wilke RA; Kroemer HK; Stein CM Circulation; 2011 Apr; 123(15):1661-70. PubMed ID: 21502584 [No Abstract] [Full Text] [Related]
11. Pharmacogenetics in cardiovascular disorders: an update on the principal drugs. Predazzi IM; Mango R; Norata GD; Di Daniele N; Sergi D; Romeo F; Novelli G Am J Cardiovasc Drugs; 2013 Apr; 13(2):79-85. PubMed ID: 23539170 [TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics in cardiovascular diseases: State of the art and implementation-recommendations of the French National Network of Pharmacogenetics (RNPGx). Lamoureux F; Duflot T; Therapie; 2017 Apr; 72(2):257-267. PubMed ID: 28237404 [TBL] [Abstract][Full Text] [Related]
13. Personalised medicine: not just in our genes. Kitsios GD; Kent DM BMJ; 2012 Apr; 344():e2161. PubMed ID: 22491484 [TBL] [Abstract][Full Text] [Related]
14. [Pharmacogenomics of cardiovascular pharmacology]. Tanaka T; Oka T; Iwao H Nihon Yakurigaku Zasshi; 2006 Sep; 128(3):130-2. PubMed ID: 16971774 [No Abstract] [Full Text] [Related]
15. Pharmacogenomics and drug response in cardiovascular disorders. Siest G; Jeannesson E; Berrahmoune H; Maumus S; Marteau JB; Mohr S; Visvikis S Pharmacogenomics; 2004 Oct; 5(7):779-802. PubMed ID: 15469403 [TBL] [Abstract][Full Text] [Related]
16. The pharmacogenetics research network: from SNP discovery to clinical drug response. Giacomini KM; Brett CM; Altman RB; Benowitz NL; Dolan ME; Flockhart DA; Johnson JA; Hayes DF; Klein T; Krauss RM; Kroetz DL; McLeod HL; Nguyen AT; Ratain MJ; Relling MV; Reus V; Roden DM; Schaefer CA; Shuldiner AR; Skaar T; Tantisira K; Tyndale RF; Wang L; Weinshilboum RM; Weiss ST; Zineh I; Clin Pharmacol Ther; 2007 Mar; 81(3):328-45. PubMed ID: 17339863 [TBL] [Abstract][Full Text] [Related]
17. Cardiovascular therapy and pharmacogenetics in 2007. Carlquist J Pharmacogenomics; 2007 Jan; 8(1):21-3. PubMed ID: 17187505 [TBL] [Abstract][Full Text] [Related]